4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-023557
CHIEF CORP. & COMM. OFFICER gave up 3,300 shares (to pay taxes)
- CHIEF CORP. & COMM. OFFICER acquired 6,823 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Moat Ross · CHIEF CORP. & COMM. OFFICER
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-01 | Exercise or conversion : show line 1 in the form | +1,741 | 11,156 | D | ||
| 2025-09-01 | Exercise or conversion : show line 2 in the form | +1,611 | 12,767 | D | ||
| 2025-09-01 | Exercise or conversion : show line 3 in the form | +2,477 | 15,244 | D | ||
| 2025-09-01 | Shares withheld for taxes : show line 4 in the form | −2,819 | $33.49 | $94,408 | 12,425 | D |
| 2025-09-02 | Exercise or conversion : show line 5 in the form | +994 | 13,419 | D | ||
| 2025-09-02 | Shares withheld for taxes : show line 6 in the form | −481 | $34.28 | $16,489 | 12,938 | D |
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-01 | Grant or award : show line 7 in the form Restricted Share Unit | +9,828 | 9,828 | D |
| 2025-09-01 | Grant or award : show line 8 in the form Share Option | +39,364 | 39,364 | D |
| 2025-09-01 | Exercise or conversion : show line 9 in the form Restricted Share Unit | −1,741 | 5,221 | D |
| 2025-09-01 | Exercise or conversion : show line 10 in the form Restricted Share Unit | −1,611 | 3,222 | D |
| 2025-09-01 | Exercise or conversion : show line 11 in the form Restricted Share Unit | −2,477 | 2,477 | D |
| 2025-09-02 | Exercise or conversion : show line 12 in the form Restricted Share Unit | −994 | 0 | D |
Loading xslF345X05/form4-09032025_080909.xml…